PeptideKey News

$89M Fuels Pinnacle Oral Peptides: What's Next by [2026]?

Pinnacle Medicines raised $89M Series B for AI-driven oral peptide delivery. Backed by RA Capital, Foresite, OrbiMed. Total raised: $134M pre-clinical.

Loading full content...